loadpatents
name:-0.029988050460815
name:-0.012001037597656
name:-0.00288987159729
Tarsi; Luca Patent Filings

Tarsi; Luca

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tarsi; Luca.The latest application filed is for "dopamine d3 receptor antagonist compounds".

Company Profile
2.14.22
  • Tarsi; Luca - Verona IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dopamine D.sub.3 receptor antagonist compounds
Grant 10,654,842 - Cremonesi , et al.
2020-05-19
Substituted 3,6-diazabicyclo[3.2.0]heptanes
Grant 10,584,135 - Cremonesi , et al.
2020-03-10
Dopamine D3 receptor antagonists having a morpholine moiety
Grant 10,577,361 - Cremonesi , et al.
2020-03-03
Dopamine D3 Receptor Antagonist Compounds
App 20190300514 - Cremonesi; Susanna ;   et al.
2019-10-03
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety
App 20190194225 - Cremonesi; Susanna ;   et al.
2019-06-27
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators
Grant 10,273,244 - Micheli , et al.
2019-04-30
Dopamine D3 receptor antagonists
Grant 10,239,870 - Cremonesi , et al.
2019-03-26
Dopamine D3 Receptor Antagonists Having A Morpholine Moiety
App 20180297990 - Cremonesi; Susana ;   et al.
2018-10-18
Dopamine D3 Receptor Antagonists
App 20180282318 - Cremonesi; Susanna ;   et al.
2018-10-04
Dopamine D3 Receptor Antagonists Having A Bicyclo Moiety
App 20180222918 - Cremonesi; Susanna ;   et al.
2018-08-09
Dopamine D3 receptor antagonist compounds
Grant 10,000,477 - Cremonesi , et al. June 19, 2
2018-06-19
N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system
Grant 9,920,053 - Cremonesi , et al. March 20, 2
2018-03-20
Dopamine D3 Receptor Antagonist Compounds
App 20170334895 - Cremonesi; Susanna ;   et al.
2017-11-23
2-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[4.5]decan-10-one Derivatives And Related Compounds As Inhibitors Of The Human Dopamine-active-transporter (dat) Protein For The Treatment Of E.g. Attention Deficit Disorder (add)
App 20170260185 - SEMERARO; Teresa ;   et al.
2017-09-14
N-(hetero)aryl-substituted Heteroyclic Derivatives Useful For The Treatment Of Diseases Or Conditions Related To The Central Nervous System
App 20170253592 - CREMONESI; Susanna ;   et al.
2017-09-07
Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D.sub.3 receptors
Grant 8,263,782 - Arista , et al. September 11, 2
2012-09-11
Spirocompounds useful as modulators for dopamine D3 receptors
Grant 8,030,322 - Bertani , et al. October 4, 2
2011-10-04
7-pyrazolylbenzazepines having affinity for D3 receptor
Grant 8,003,638 - Hamprecht , et al. August 23, 2
2011-08-23
Compounds having affinity for dopamine D3 receptor and uses thereof
Grant 7,989,444 - Bonanomi , et al. August 2, 2
2011-08-02
3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors
Grant 7,947,683 - Bonanomi , et al. May 24, 2
2011-05-24
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D.sub.3 receptors
Grant 7,855,298 - Arista , et al. December 21, 2
2010-12-21
Triazole derivatives as modulators of dopamine D3 receptors
Grant 7,799,815 - Bonanomi , et al. September 21, 2
2010-09-21
Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
App 20100160336 - Arista; Luca ;   et al.
2010-06-24
Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
App 20100152195 - Arista; Luca ;   et al.
2010-06-17
Spirocompounds Useful As Modulators For Dopamine D3 Receptors
App 20100063078 - Bertani; Barbara ;   et al.
2010-03-11
Compounds Having Affinity For Dopamine D3 Receptor And Uses Thereof"
App 20100016287 - Bonanomi; Giorgio ;   et al.
2010-01-21
Triazole Derivatives As Modulators Of Dopamine D3 Receptors
App 20090221593 - Bonanomi; Giorgio ;   et al.
2009-09-03
3-(1,2,4-triazol-3ylalkyl) Azabriclo (3.1.0) Hexane Derivatives As Modulators Of Dopamine D3 Receptors
App 20090124629 - Bonanomi; Giorgio ;   et al.
2009-05-14
7-Pyrazolylbenzazepines Having Affinity For D3 Receptor
App 20080312213 - Hamprecht; Dieter ;   et al.
2008-12-18
Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine
App 20080269195 - Bonanomi; Giorgio ;   et al.
2008-10-30
Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)
App 20080139532 - Arista; Luca ;   et al.
2008-06-12
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine d3 receptors
App 20070142438 - Arista; Luca ;   et al.
2007-06-21
Macrolide Antibiotics
App 20060211636 - ALIHODZIC; Sulejman ;   et al.
2006-09-21
Macrolide antibiotics
App 20050215495 - Alihodzic, Sulejman ;   et al.
2005-09-29
Macrolide antibiotics
App 20040077557 - Ali, Sulejman ;   et al.
2004-04-22
Tricyclic carbapenem compounds
App 20010047094 - Rossi, Tino ;   et al.
2001-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed